menu
    • menu

    Company profile for Medicus Pharma

    NEW Drugs in Dev: 4
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Medicus Pharma Ltd is a biotech company focused on advancing novel therapeutic assets through clinical development. With extensive industry experience, the company aims to improve patient safety and efficacy by addressing unmet medical needs. Medicus follows a collaborative process to identify and advance promising clinical-stage assets. Additionally, the company is exploring opportunities for pipeline expansion through strate...
    Medicus Pharma Ltd is a biotech company focused on advancing novel therapeutic assets through clinical development. With extensive industry experience, the company aims to improve patient safety and efficacy by addressing unmet medical needs. Medicus follows a collaborative process to identify and advance promising clinical-stage assets. Additionally, the company is exploring opportunities for pipeline expansion through strategic acquisitions and partnerships.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Medicus PharmaCanada Flag
    Country
    Country
    Canada
    Address
    Address
    100 King St W Suite 3400, Toronto, ON M5X 1A4
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://medicuspharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Medicus Pharma Seeks FDA Orphan Drug Designation For Skinject
    Medicus Pharma Seeks FDA Orphan Drug Designation For Skinject

    19 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7187515

    FIRSTWORD PHARMA
    19 Apr 2026
    Share Share
    Medicus Pharma To Unveil Long-Acting Teverelix Data At AACE 2026
    Medicus Pharma To Unveil Long-Acting Teverelix Data At AACE 2026

    15 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/15/3274336/0/en/Medicus-Pharma-to-Present-New-Teverelix-Data-at-AACE-2026-Demonstrating-Long-Acting-Hormone-Suppression.html

    GLOBENEWSWIRE
    15 Apr 2026
    Share Share
    Medicus Pharma Ltd Clarifies Positive Skinject Phase 2 Dataset
    Medicus Pharma Ltd Clarifies Positive Skinject Phase 2 Dataset

    01 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/01/3266511/0/en/Medicus-Pharma-Ltd-Clarifies-Positive-SkinJect-Phase-2-Dataset.html

    GLOBENEWSWIRE
    01 Apr 2026
    Share Share
    Medicus SkinJect Ph2 Shows 80% ORR With KOL Validation
    Medicus SkinJect Ph2 Shows 80% ORR With KOL Validation

    30 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/30/3264524/0/en/Medicus-Pharma-Reports-KOL-Validation-of-SkinJect-Phase-2-Data-of-80-Overall-Response-Rate.html

    GLOBENEWSWIRE
    30 Mar 2026
    Share Share
    Medicus Pharma: 80% ORR in Phase 2 SkinJect, Unveils AI Platform
    Medicus Pharma: 80% ORR in Phase 2 SkinJect, Unveils AI Platform

    26 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/26/3262893/0/en/Medicus-Pharma-Business-Update-Call-to-Highlight-80-Overall-Response-Rate-ORR-in-Phase-2-SkinJect-Study-and-Agentic-AI-enabled-Drug-Development-Plan.html

    GLOBENEWSWIRE
    26 Mar 2026
    Share Share
    Medicus Pharma Reveals 2025 Financials And Corporate Update
    Medicus Pharma Reveals 2025 Financials And Corporate Update

    25 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-25/medicus-pharma-reports-full-year-2025-financial-results-and-provides-corporate-update

    PHARMIWEB
    25 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search